Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125223801 | 12522380 | 1 | I | 201512 | 20160623 | 20160701 | 20160701 | EXP | US-ABBVIE-16K-163-1660489-00 | ABBVIE | 44.19 | YR | F | Y | 0.00000 | 20160701 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125223801 | 12522380 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 125223801 | 12522380 | 2 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125223801 | 12522380 | 1 | Psoriatic arthropathy |
| 125223801 | 12522380 | 2 | Eye disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125223801 | 12522380 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125223801 | 12522380 | Abdominal discomfort | |
| 125223801 | 12522380 | Arthropathy | |
| 125223801 | 12522380 | Eye disorder | |
| 125223801 | 12522380 | Fatigue | |
| 125223801 | 12522380 | Inflammation | |
| 125223801 | 12522380 | Rash macular | |
| 125223801 | 12522380 | Skin exfoliation | |
| 125223801 | 12522380 | Skin irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125223801 | 12522380 | 1 | 201303 | 0 | ||
| 125223801 | 12522380 | 2 | 2016 | 0 |